Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Mao vs Rao: Cell Press probe clears editor but Chinese biologist keeps up pressure

Prominent biologist Rao Yi is refusing to back down after Cell Press said it had found no evidence that top journal editor Steve Mao sought bribes from Chinese scientists. In a statement published on Thursday evening, Cell Press – one of the world’s leading scientific publishers, owned by Elsevier – said its investigation had “largely concluded” and “found no evidence to support the…

Mao vs Rao: Cell Press probe clears editor but Chinese biologist keeps up pressure

Cell Press, a leading scientific publisher owned by Elsevier, has completed an investigation into allegations that Cancer Cell editor-in-chief Steve Mao sought bribes from Chinese scientists. The investigation found no evidence to support these claims. However, biologist Rao Yi, who accused Mao of engaging in bribery, remains critical of the journal's editor.

Rao stated that if Mao does not resign or sue him for defamation, it would indicate a problem within the journal. The South China Morning Post attempted to contact Rao for more information but received no response.

Written by urgent.news from Reuters Business via SCMP's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at scmp.com →

More in Finance & Markets

Sun Pharma Q2 profit takes a hit on exceptional items

Sun Pharmaceutical has seen a notable 36% drop in net profit, juxtaposed with an 11.8% rise in consolidated revenue. The uplift in revenue can be attributed largely to strong sales growth in India and…

  • Sun Pharma's net profit declined 36% to ₹1,989 crore in Q2 due to exceptional items.
  • Overall revenue rose 11.8% to ₹16,100 crore, with India and emerging markets driving growth.
  • Adjusted net profit was ₹3,162 crore, EBITDA increased 4.8% to ₹4,744 crore.

More from Saturday 31 October →